4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000087
Director acquired 148,710.49 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SPRINGER TIMOTHY A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-15 | Grant or award : show line 1 in the form | +24,785.08 | $403.47 | $9,999,999 | 24,785.08 | I |
| 2023-11-15 | Grant or award : show line 2 in the form | +123,925.41 | $403.47 | $49,999,998 | 123,925.41 | D |
Table II: Derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-13 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −6,410 | 0 | D | ||
| 2023-11-13 | Returned to the company : show line 4 in the form Stock Option (Right to Buy) | −10,000 | 0 | D | ||
| 2023-11-13 | Returned to the company : show line 5 in the form Stock Option (Right to Buy) | −10,000 | 0 | D | ||
| 2023-11-13 | Returned to the company : show line 6 in the form Stock Option (Right to Buy) | −20,000 | 0 | D | ||
| 2023-11-13 | Returned to the company : show line 7 in the form Stock Option (Right to Buy) | −40,000 | 0 | D | ||
| 2023-11-13 | Returned to the company : show line 8 in the form Stock Option (Right to Buy) | −40,000 | 0 | D | ||
| 2023-11-13 | Returned to the company : show line 9 in the form Stock Option (Right to Buy) | −75,000 | $0.93 | $69,750 | 0 | D |
Loading xslF345X05/wk-form4_1700086801.xml…